1-tert-Butoxycarbonyl-3-hydroxy piperidine, 98.0%, 5g

4-CHLOROIMIDAZO[1,2-A]QUINOXALINE, 97.0%, 1g

1-isopropyl-5-methyl-1H-pyrazole-3-carbonyl chloride, 95.0%, 250mg

4,6-Dibromopicolinic acid, 95+%, 250mg

(2-oxo-1,2-dihydro-3H-indol-3-ylidene)malononitrile, 95.0%, 100mg

Xantphos, min. 98%, 5 g, glass packaging

Methyl 2-fluoro-5-methylpyridine-3-carboxylate, 97%, 500mg

Ethyl 4-methoxypyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 1g

2-(4-(2-Bromopropanoyl)phenoxy)acetic acid, 95.0%, 100mg

4-(4-Chlorophenyl)-2-(piperazin-1-yl)-6-(trifluoromethyl)pyrimidine, 95%, 25mg

D-(-)-Lyxose>98.0%(HPLC)1g

(3-Methoxy-5-nitrophenyl)methanol, 98%, 100mg

Sodium 2,5-dihydroxybenzoate, 95.0%, 500g